Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;174(1):W17.
doi: 10.7326/L20-1355. Epub 2020 Dec 1.

Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey  1 , Devan Kansagara  1 , Kathryn Vela  1
Affiliations
Comment

Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults

Katherine Mackey et al. Ann Intern Med. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L20-1355.

Comment on

References

    1. Mackey K , King VJ , Gurley S , et al. Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review. Ann Intern Med. 2020;173:195-203. doi: 10.7326/M20-1515 - DOI - PMC - PubMed
    1. Dublin S , Walker R , Floyd JS , et al. Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study. Am J Hypertens. 2020. [PMID: ] doi: 10.1093/ajh/hpaa168 - DOI - PMC - PubMed
    1. Braude P , Carter B , Short R , et al. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19. Int J Cardiol Heart Vasc. 2020;31:100660. [PMID: ] doi: 10.1016/j.ijcha.2020.100660 - DOI - PMC - PubMed
    1. Covino M , De Matteis G , Burzo ML , et al; GEMELLI AGAINST COVID-19 Group. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalized with Covid-19. Intern Med J. 2020. [PMID: ] doi: 10.1111/imj.15078 - DOI - PMC - PubMed
    1. Cui H , Wu F , Fan Z , et al. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: a retrospective, single-center trial. Med Clin (Engl Ed). 2020;155:295-298. [PMID: ] doi: 10.1016/j.medcle.2020.06.007 - DOI - PMC - PubMed

Substances